caus
recent
affect
peopl
kill
manner
key
immun
cell
subset
chang
state
cours
remain
unclear
appli
singlecel
technolog
comprehens
character
transcript
chang
peripher
blood
mononuclear
cell
recoveri
stage
compar
healthi
control
patient
earli
recoveri
stage
er
cell
decreas
remark
wherea
monocyt
increas
detail
analysi
monocyt
reveal
increas
ratio
classic
monocyt
high
inflammatori
gene
express
well
greater
abund
monocyt
er
cell
decreas
significantli
express
high
level
inflammatori
gene
er
among
b
cell
plasma
cell
increas
remark
wherea
b
cell
decreas
studi
identifi
sever
novel
b
cellreceptor
bcr
chang
confirm
isotyp
previous
use
viru
vaccin
develop
strongest
pair
frequenc
indic
monoclon
state
associ
specif
furthermor
integr
analysi
predict
mcsf
may
novel
candid
target
gene
inflammatori
storm
may
benefici
recoveri
patient
studi
provid
first
evid
inflammatori
immun
signatur
er
suggest
patient
still
vulner
hospit
discharg
identif
novel
bcr
signal
may
lead
develop
vaccin
antibodi
treatment
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
immun
respons
sustain
day
earli
recoveri
stage
suggest
patient
still
vulner
hospit
discharg
singlecel
analysi
reveal
predomin
subset
monocyt
patient
er
newli
identifi
virusspecif
b
cellreceptor
chang
could
help
develop
vaccin
antibodi
mcsf
discov
novel
mediat
inflammatori
cytokin
storm
may
benefici
recoveri
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
caus
sever
acut
respiratori
syndrom
coronaviru
spread
mani
countri
march
affect
peopl
kill
affect
countri
follow
global
spread
world
health
organ
declar
public
health
emerg
intern
concern
show
symptom
fever
dri
cough
fatigu
diarrhea
conjunct
pneumonia
patient
develop
sever
pneumonia
acut
respiratori
distress
syndrom
ard
multipl
organ
failur
although
scientist
clinician
worldwid
made
great
effort
produc
vaccin
explor
antivir
drug
still
specif
medicin
effect
clinic
treatment
immun
system
dysregul
lymphopenia
inflammatori
cytokin
storm
observ
believ
associ
sever
pathogen
coronaviru
infect
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
infect
regard
recent
studi
also
found
decreas
lymphocyt
number
increas
serum
inflammatori
cytokin
level
peripher
blood
howev
manner
key
immun
cell
subset
chang
state
remain
larg
unclear
thu
defin
key
cellular
subset
state
crucial
step
obtain
critic
insight
immun
clearanc
mechan
develop
new
therapeut
strategi
appli
singlecel
rna
sequenc
scrnaseq
comprehens
character
chang
peripher
blood
mononuclear
cell
pbmc
patient
studi
depict
highresolut
transcriptom
landscap
blood
immun
cell
subset
recoveri
stage
reveal
compar
healthi
control
hc
monocyt
contain
high
inflammatori
gene
express
subset
predomin
wherea
cell
decreas
remark
patient
earli
recoveri
stage
found
b
cell
clone
highli
expand
recoveri
stage
patient
furthermor
sever
specif
bcr
chang
patient
recoveri
stage
may
help
vaccin
antibodi
product
map
immun
microenviron
patient
identifi
mirror
chang
blood
pinpoint
cellspecif
alter
associ
diseas
sever
recoveri
integr
singlecel
rna
sequenc
scrnaseq
singlecel
pair
bcr
singlecel
pair
tcr
analysi
total
patient
earli
recoveri
stage
er
late
recoveri
stage
lr
pbmc
also
collect
scrnaseq
data
cell
five
healthi
donor
control
fig
fig
dataset
pass
stringent
highqual
filter
singlecel
suspens
scrnaseq
sampl
convert
barcod
scrnaseq
librari
use
genom
cellrang
softwar
version
use
initi
process
sequenc
data
use
tdistribut
stochast
neighbor
embed
tsne
analyz
distribut
three
immun
cell
lineag
myeloid
nkt
b
cell
base
express
canon
lineag
marker
gene
specif
upregul
cluster
fig
c
marker
gene
express
valu
cell
posit
tsne
shown
fig
next
cluster
cell
lineag
separ
identifi
total
immun
cell
cluster
immun
cell
compart
patient
recov
infect
compris
major
immun
lineag
analyz
scrnaseq
profil
pass
qualiti
control
includ
myeloid
cell
nkt
cell
b
cell
five
hc
five
er
five
lr
patient
sketchi
cluster
analysi
landscap
subject
present
fig
merg
imag
group
shown
fig
discov
patient
includ
er
lr
demonstr
higher
proport
myeloid
cell
compar
hc
lower
proport
nkt
cell
fig
c
interestingli
lr
patient
b
cell
nkt
cell
less
myeloid
cell
er
patient
fig
c
thu
find
indic
patient
decreas
lymphocyt
count
increas
count
myeloid
cell
peripher
blood
understand
chang
myeloid
nkt
b
cell
patient
conduct
differenti
express
gene
deg
analysi
nkt
b
myeloid
cell
hc
patient
heat
map
shown
fig
f
inflammatori
cytokin
chemokin
jun
fo
express
high
level
patient
regardless
myeloid
cell
fig
nkt
cell
fig
b
cell
fig
collect
result
demonstr
myeloid
cell
increas
wherea
nkt
cell
decreas
peripher
blood
patient
immun
cell
composit
differ
patient
er
lr
understand
chang
monocyt
patient
earli
late
recoveri
stage
conduct
gene
express
analysi
subclust
myeloid
cell
six
transcript
distinct
subset
use
uniform
manifold
approxim
project
umap
classic
monocyt
nonclass
monocyt
intermedi
monocyt
pdc
present
six
distinct
cluster
fig
b
found
compart
monocyt
subset
differ
remark
among
hc
patient
fig
among
myeloid
cell
ratio
classic
monocyt
higher
er
patient
hc
almost
normal
lr
patient
fig
found
patient
greater
abund
monocyt
ifnactiv
monocyt
hc
fig
gene
associ
inflammatori
monocyt
high
express
level
inflammatori
gene
jun
fo
junb
chemokin
interferonstimul
gene
contrast
antiinflammatori
gene
associ
monocyt
downregul
patient
rel
hc
fig
e
notabl
express
valu
umap
simultan
contrast
indic
upregul
er
group
decreas
lr
patient
fig
also
confirm
dc
cluster
er
group
compar
hc
fig
next
took
averag
inflammatori
gene
myeloid
cell
scrnaseq
subset
patient
versu
hc
fig
result
demonstr
cytokin
activ
drive
expans
monocyt
popul
especi
inflammatori
monocyt
patient
explor
biolog
signific
transcript
chang
cluster
perform
go
analysi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
deg
fig
observ
enrich
pathway
relat
cytokin
signal
inflamm
activ
driven
upregul
jun
fo
junb
fig
collect
find
demonstr
dysregul
balanc
monocyt
popul
er
patient
manifest
substanti
increas
classic
monocyt
result
suggest
classic
monocyt
increas
circul
fuel
inflamm
nk
cell
play
critic
role
viral
clearanc
respiratori
infect
cluster
analysi
subgroup
nk
lymphocyt
subset
subdivid
nk
cell
nk
cell
express
high
level
low
level
nk
cell
express
high
level
low
level
cell
express
subdivid
cell
four
cluster
cell
express
high
level
central
memori
cell
tcm
express
high
level
compar
cell
effector
memori
cell
tem
express
high
level
regulatori
cell
treg
express
cell
express
subdivid
three
cluster
cell
express
high
level
similar
cell
effector
memori
cell
tm
express
high
level
gzmk
cytotox
lymphocyt
ctl
express
high
level
gzmb
gnli
prolifer
cell
prot
tym
cell
composit
nk
cell
subset
differ
significantli
among
hc
patient
fig
ratio
cell
decreas
er
patient
wherea
ratio
nk
cell
higher
hc
ratio
cell
stabl
composit
cell
subset
differ
significantli
hc
patient
among
cell
central
memori
cell
significantli
higher
wherea
ratio
cell
lower
that
hc
notabl
gene
associ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
cell
rel
high
express
level
inflammationrel
gene
significantli
upregul
patient
fig
cell
high
express
level
inflammatori
gene
includ
fo
jun
patient
er
fig
contrast
antiinflammatori
gene
associ
cell
downregul
patient
rel
hc
fig
e
suggest
cell
main
particip
viru
infect
comparison
deg
cell
reveal
enrich
gene
particip
cytokin
pathway
inflamm
activ
includ
jun
fo
junb
fig
studi
need
elucid
ifn
pathway
involv
pathogenesi
tcrseq
analysi
show
cell
expans
obvious
decreas
er
group
hc
group
fig
moreov
central
memori
cell
show
littl
clonal
expans
effector
memori
cell
termin
effector
cell
ctl
prolifer
cell
show
higher
expans
level
fig
addit
highli
expand
maximum
clone
er
group
fig
decreas
ratio
cell
patient
may
implic
role
cell
viru
clearanc
fig
moreov
ctl
expand
clone
also
exhibit
overactiv
inflamm
antivir
activ
compar
hc
fig
fig
togeth
find
show
clonal
expand
cell
peripher
blood
patient
help
control
viru
also
perform
deg
analysi
via
unsupervis
cluster
analysi
found
overactiv
inflammatori
state
prot
cell
fig
next
took
averag
inflammatori
gene
nkt
cell
subset
scrnaseq
subset
patient
versu
normal
rnaseq
data
fig
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
comparison
hc
percentag
plasma
cell
increas
significantli
patient
wherea
b
cell
decreas
significantli
patient
fig
infect
develop
adopt
immun
synergist
work
induc
specif
antibodi
moreov
compar
hc
b
cell
activationrel
gene
includ
primarili
express
mpb
er
group
fig
also
found
similar
result
plasma
cell
antibodysecret
cell
asc
fig
singlecel
bcrseq
analysi
indic
iga
isotyp
overrepres
patient
compar
hc
fig
correspond
increas
level
serum
iga
also
pronounc
coronaviru
infect
moreov
ratio
igaiggig
igdigm
increas
significantli
er
patient
show
downward
trend
recoveri
time
fig
use
scbcrseq
assess
statu
clonal
expans
blood
patient
found
b
cell
show
littl
clonal
expans
wherea
memori
b
cell
show
highest
expans
level
among
divers
b
cell
subset
fig
individu
level
found
patient
significantli
expand
clone
compar
hc
support
assumpt
b
cell
experienc
uniqu
clonal
vdj
rearrang
infect
also
found
higher
b
cell
clonal
consist
remain
er
compar
lr
patient
fig
moreov
quantif
highli
expand
maximum
clone
subject
show
ratio
maximum
clone
higher
er
group
hc
fig
understand
function
statu
expand
clone
b
cell
perform
deg
analysi
clone
memori
b
cell
b
cell
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
result
reveal
increas
express
b
cell
gene
includ
support
superior
effector
function
expand
clone
b
cell
fig
moreov
differenti
gene
expand
b
cell
significantli
subsid
time
reduc
lr
patient
fig
studi
uniqu
chang
prefer
gene
bcr
patient
compar
usag
vdj
gene
patient
hc
identifi
overrepresent
famili
especi
patient
compar
hc
fig
prefer
iglv
wherea
prefer
igkv
moreov
top
two
pair
frequenc
er
patient
fig
cell
show
igh
subunit
pair
iglv
subunit
encod
respect
indic
expand
state
associ
specif
individu
maximum
clone
refer
fig
fig
respect
summari
increas
clonal
domin
iga
igm
isotyp
togeth
skew
use
ighv
gene
suggest
contribut
pathogenesi
notabl
bias
usag
domin
igv
gene
especi
patient
provid
framework
ration
design
vaccin
establish
comput
approach
use
predict
celltocel
interact
may
contribut
distinct
function
state
cell
b
cell
monocyt
dendrit
cell
dc
er
lr
fig
b
er
patient
found
adapt
signal
involv
monocyt
activ
prolifer
inflammatori
signal
fig
b
cell
express
gene
encod
ligand
lta
ifng
ltb
ltbr
express
monocyt
could
contribut
proinflammatori
statu
cellmonocyt
interact
involv
express
cell
might
activ
monocyt
express
bind
csfr
contribut
inflammatori
storm
cluster
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
monocyt
exclus
express
predict
bind
express
cell
cellmonocyt
interact
may
enhanc
immun
respons
exclus
patient
fig
b
furthermor
found
monocyt
highli
express
polioviru
receptor
serv
cellular
receptor
polioviru
first
step
polioviru
replic
induct
nfkappa
b
signal
pathway
b
cellmonocyt
b
cellt
cell
interact
found
b
cell
could
secret
larg
number
lta
ltb
combin
ltar
ltbr
express
monocyt
larg
amount
appli
cell
promot
secret
inflammatori
cytokin
chemokin
thu
cascad
signatur
inflammatori
monocyt
high
express
progeni
form
peak
incid
er
patient
fig
activ
immun
cell
may
enter
circul
lung
organ
larg
number
play
immunedamag
role
lr
patient
dc
ligand
predict
interact
b
cell
receptor
involv
cell
prolifer
product
antibodi
discov
peripher
blood
lr
patient
contain
divers
antibodi
found
highli
express
analysi
dcb
cell
interact
fig
thu
specul
dc
produc
promot
prolifer
b
cell
secret
mani
antibodi
blood
er
dct
cellb
cell
interact
discov
dc
produc
also
promot
prolifer
cell
moreov
cell
produc
promot
prolifer
b
cell
antibodi
fig
thu
celltocel
interact
help
us
understand
patient
manifest
high
rate
monocyt
low
rate
lymphocyt
proport
lymphocyt
gradual
increas
peripher
blood
recov
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
clinic
present
vari
asymptomat
sever
ard
similarli
observ
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
influenza
infect
viral
infect
gener
accept
host
immun
respons
determin
protect
viral
infect
pathogenesi
respiratori
injuri
coordin
respons
innat
adapt
immun
cell
work
concert
may
lead
rapid
control
viru
wherea
fail
immun
respons
might
lead
viral
spread
cytokin
storm
high
mortal
rate
despit
belong
group
virus
recent
studi
highlight
differ
sar
mer
speed
transmiss
treatment
scheme
mortal
rate
moreov
differ
may
also
exist
key
immun
player
underli
molecular
mechan
relat
diseas
lack
knowledg
regard
immun
impact
becom
critic
issu
view
rapid
spread
shortag
specif
therapi
use
singlecel
sequenc
profil
complex
immun
popul
blood
analyz
cell
patient
identifi
hyperinflammatori
respons
er
patient
may
explain
patient
fell
sick
discharg
suggest
current
criteria
hospit
discharg
reevalu
addit
identifi
uniqu
signatur
myeloid
nkt
b
cell
pinpoint
chang
epitop
tcr
bcr
find
help
elucid
antivir
immun
mechan
reveal
promis
opportun
develop
immunotherapi
use
vaccin
neutral
antibodi
inflamm
vital
part
immun
system
respons
invas
previou
latest
studi
report
significantli
higher
level
inflammatori
cytokin
associ
diseas
sever
sar
mer
patient
among
variou
inflammatori
cell
monocyt
subset
includ
classic
intermedi
nonclass
monocyt
may
play
critic
role
known
fuel
inflamm
studi
compar
hc
er
patient
demonstr
significantli
higher
ratio
monocyt
cell
express
higher
level
inflammatori
gene
intriguingli
ratio
classic
monocyt
high
er
remain
normal
lr
furthermor
monocyt
absent
hc
could
observ
er
declin
number
lr
notabl
celltocel
interact
analysi
indic
may
associ
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
cytokin
storm
collect
data
provid
import
insight
role
monocyt
immunopathogenesi
adapt
immun
system
harbor
abil
recogn
rememb
specif
pathogen
antibodi
cell
respons
induc
adapt
immun
aim
vaccin
previou
sar
studi
identifi
bind
neutral
antibodi
elicit
sarscov
infect
therapeut
effect
unclear
although
robust
antibodi
respons
could
induc
infect
although
sever
line
evid
consist
indic
declin
lymphocyt
count
distinct
immun
characterist
singlecel
resolut
unclear
scrnaseq
analysi
show
compar
hc
er
patient
lower
ratio
nk
cell
patient
cell
express
higher
level
inflammatori
gene
jun
fo
junb
addit
highthroughput
tcr
sequenc
identifi
expand
cell
clone
er
patient
lr
patient
immunophenotyp
differ
particular
lr
patient
would
increas
nk
cell
lower
express
inflammatori
gene
also
perform
detail
analysi
b
cell
patient
identifi
higher
popul
plasma
cell
hc
found
bcr
contain
highli
expand
clone
indic
specif
importantli
found
sever
loci
uniqu
infect
strongest
pair
frequenc
indic
monoclon
state
associ
specif
notabl
numer
studi
report
bias
usag
vdj
gene
relat
virusspecif
antibodi
exampl
involv
encod
primari
antibodi
neutral
human
cytomegaloviru
addit
util
isol
influenza
viru
antibodi
use
product
viru
vaccin
moreov
recent
studi
demonstr
antibodi
combin
segment
superior
neutral
activ
zair
ebola
viru
addit
observ
lower
express
inflammatori
gene
er
patient
hc
envis
result
provid
direct
develop
vaccin
antibodi
patient
celltocel
predict
analysi
util
scrnaseq
data
indic
er
patient
b
cellderiv
cellderiv
mcsf
gmcsf
may
promot
monocyt
prolifer
activ
result
monocyt
may
produc
larger
number
inflammatori
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
mediat
includ
contribut
inflammatori
storm
lr
patient
dcsderiv
cellderiv
may
promot
b
cell
surviv
prolifer
differenti
consequ
b
cell
produc
numer
antibodi
clear
virus
conclus
studi
provid
first
immun
atla
patient
recov
identifi
adapt
immun
dysregul
discharg
clonal
expans
b
cell
indic
immun
system
gradual
recov
howev
sustain
hyperinflammatori
respons
day
discharg
suggest
need
medic
observ
patient
discharg
hospit
longitudin
studi
recov
patient
larger
cohort
might
help
understand
consequ
diseas
novel
bcr
identifi
studi
may
advanc
understand
b
cell
mechan
potenti
clinic
util
immunotherapi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
healthi
donor
use
ficollhypaqu
densiti
solut
accord
standard
densiti
gradient
centrifug
method
sampl
cell
viabil
exceed
singlecel
suspens
scrnaseq
sampl
convert
barcod
scrnaseq
librari
use
chromium
singl
cell
librari
gel
bead
multiplex
kit
chip
kit
genom
chromium
singl
cell
reagent
genom
kit
use
prepar
singlecel
rna
librari
accord
manufactur
instruct
fastqc
softwar
use
qualiti
check
cellrang
softwar
version
use
initi
process
sequenc
data
demultipl
barcod
sampl
use
cell
ranger
softwar
suit
version
command
cellrang
count
get
sampl
gene
count
aggreg
togeth
final
genebarcod
matrix
ten
patient
five
hc
integr
seurat
follow
criteria
appli
cell
ie
gene
number
handl
data
log
normal
cluster
reduct
scale
data
top
variabl
gene
cluster
dimension
method
mainli
use
packag
gene
use
pca
analysi
elimin
mitochondria
mt
ribosom
rpl
rp
gene
includ
etal
princip
compon
align
togeth
follow
umap
tsne
use
result
align
paramet
use
default
paramet
insid
leiden
method
umap
dimens
use
seurat
monocl
use
perform
differenti
analysi
cluster
differentiallyexpress
gene
deg
gener
rel
cell
deg
gene
ontolog
go
kegg
pathway
analys
perform
use
metascap
webtool
wwwmetascapeorg
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
fulllength
tcrbcr
v
j
segment
enrich
amplifi
cdna
librari
via
pcr
amplif
use
chromium
singlecel
v
j
enrich
kit
accord
manufactur
protocol
genom
tcrbcr
sequenc
singl
tb
cell
assembl
cell
ranger
vdj
pipelin
lead
identif
sequenc
rearrang
tcrbcr
gene
analysi
perform
use
loup
v
j
browser
genom
brief
tcrbcr
divers
metric
contain
clonotyp
frequenc
barcod
inform
obtain
use
barcod
inform
tb
cell
preval
tcrbcr
clonotyp
project
tsne
plot
cellcel
interact
analysi
base
express
immunerel
receptor
ligand
gene
list
contain
pair
wellannot
receptor
ligand
includ
cytokin
chemokin
costimul
estim
potenti
interact
two
cell
type
mediat
specif
ligandreceptor
pair
product
averag
express
level
ligand
one
cell
type
correspond
receptor
cell
type
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
g
pie
plot
show
tcr
clone
differ
across
hc
er
lr
patient
h
uamp
show
expand
tcr
clone
er
lr
patient
volcano
plot
show
deg
ctl
er
group
hc
h
bar
plot
show
ratio
igaiggig
igdigm
among
hc
er
lr
patient
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
